193
Last Update Posted: 2015-08-07
Recruiting has ended
Males accepted | Under |
0 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Neurobiology of Opioid Dependence: 2 - 2
The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.
Eligibility
Relevant conditions:
Opioid-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov